Published in J Rheumatol on September 01, 1993
Lupus anticoagulant and leg ulcers associated with ankylosing spondylitis. J Rheumatol (1991) 2.06
A randomized clinical trial of high-intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome (WAPS). J Thromb Haemost (2005) 3.47
Natural history and risk factors for thrombosis in 360 patients with antiphospholipid antibodies: a four-year prospective study from the Italian Registry. Am J Med (1996) 2.51
Genetic modulation of oral anticoagulation with warfarin. Thromb Haemost (2000) 1.67
Inherited thrombophilic risk factors and venous thromboembolism: distinct role in peripheral deep venous thrombosis and pulmonary embolism. Chest (2000) 1.60
High prevalence of thrombophilic genotypes in patients with acute mesenteric vein thrombosis. Am J Gastroenterol (2001) 1.60
Genetic susceptibility to pregnancy-related venous thromboembolism: roles of factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations. Am J Obstet Gynecol (1998) 1.49
Psoriatic arthritis in psoriatic patients. Br J Rheumatol (1984) 1.40
Effect of beta 2glycoprotein I and human monoclonal anticardiolipin antibody on the protein S/C4b-binding protein system. Lupus (1997) 1.40
The JAK2 V617F mutation frequently occurs in patients with portal and mesenteric venous thrombosis. J Thromb Haemost (2006) 1.37
Inherited coagulation disorders in cirrhotic patients with portal vein thrombosis. Hepatology (2000) 1.27
Increased risk for venous thrombosis in carriers of the prothrombin G-->A20210 gene variant. Ann Intern Med (1998) 1.20
The methylenetetrahydrofolate reductase TT677 genotype is associated with venous thrombosis independently of the coexistence of the FV Leiden and the prothrombin A20210 mutation. Thromb Haemost (1998) 1.13
The psoriatic arthritis cost evaluation study: a cost-of-illness study on tumour necrosis factor inhibitors in psoriatic arthritis patients with inadequate response to conventional therapy. Rheumatology (Oxford) (2008) 1.12
Predictors of stroke mortality in elderly people from the general population. The CArdiovascular STudy in the ELderly. Eur J Epidemiol (2001) 1.10
Coexistence of factor V Leiden and Factor II A20210 mutations and recurrent venous thromboembolism. Thromb Haemost (1999) 1.09
The coagulation/fibrinolysis balance in systemic sclerosis: evidence for a haematological stress syndrome. Br J Rheumatol (1997) 1.07
Psoriasis and psoriatic arthritis. Dermatological and rheumatological co-operative clinical report. Acta Derm Venereol Suppl (Stockh) (1989) 1.03
The arthritis of coeliac disease: prevalence and pattern in 200 adult patients. Br J Rheumatol (1996) 1.02
Joint symmetry in early and late rheumatoid and psoriatic arthritis: comparison with a mathematical model. Arthritis Rheum (2000) 0.97
Performance of two commercial blood IFN-gamma release assays for the detection of Mycobacterium tuberculosis infection in patient candidates for anti-TNF-alpha treatment. Eur J Clin Microbiol Infect Dis (2008) 0.96
Aortic involvement in ankylosing spondylitis. Clin Exp Rheumatol (2008) 0.94
Determinants of bone mineral density in immobilization: a study on hemiplegic patients. Osteoporos Int (1996) 0.93
Interplay between environmental factors, articular involvement, and HLA-B27 in patients with psoriatic arthritis. Ann Rheum Dis (1992) 0.92
Portal vein thrombosis after variceal endoscopic sclerotherapy in cirrhotic patients: role of genetic thrombophilia. Endoscopy (2002) 0.92
Reversibility of joint thickening in acromegalic patients: an ultrasonography study. J Clin Endocrinol Metab (1998) 0.92
Total cholesterol and mortality in the elderly. J Intern Med (2003) 0.90
High-density lipoprotein inversely relates to its specific autoantibody favoring oxidation in thrombotic primary antiphospholipid syndrome. Lupus (2010) 0.89
Thrombosis in Churg-Strauss syndrome. Beyond vasculitis? Br J Rheumatol (1996) 0.88
The arthritis of ulcerative colitis: clinical and genetic aspects. J Rheumatol (1992) 0.88
Pulse cyclophosphamide in the treatment of neuropsychiatric systemic lupus erythematosus. Clin Exp Rheumatol (1996) 0.87
Low protein Z levels and risk of occurrence of deep vein thrombosis. J Thromb Haemost (2006) 0.87
Inherited prothrombotic conditions and premature ischemic stroke: sex difference in the association with factor V Leiden. Arterioscler Thromb Vasc Biol (1999) 0.87
Cigarette smoking and appendectomy are risk factors for extraintestinal manifestations in ulcerative colitis. Am J Gastroenterol (2004) 0.86
Thrombophilic genotypes, natural anticoagulants, and plasma homocysteine in myeloproliferative disorders: relationship with splanchnic vein thrombosis and arterial disease. Am J Hematol (2003) 0.85
Premature atherosclerosis in primary antiphospholipid syndrome: preliminary data. Ann Rheum Dis (2004) 0.85
Reverse correlation between extent of colon involvement and number of affected joints in patients with ulcerative colitis and arthritis. Am J Gastroenterol (1990) 0.85
Antiphospholipid antibodies, haemostatic variables and thrombosis--a survey of 144 patients. Thromb Haemost (1995) 0.85
Ultrasonographic evidence of joint thickening reversibility in acromegalic patients treated with lanreotide for 12 months. Clin Endocrinol (Oxf) (1999) 0.84
Benign intracranial hypertension: a non-thrombotic complication of the primary antiphospholipid syndrome? Lupus (1995) 0.84
Elevated plasma lipoprotein(a) level and its association with impaired fibrinolysis in patients with antiphospholipid syndrome. J Rheumatol (1998) 0.84
Psoriatic arthritis: imaging techniques. Reumatismo (2012) 0.83
Compound heterozygosity (554-589 del, C515-T transition) in the platelet glycoprotein Ib alpha gene in a patient with a severe bleeding tendency. Thromb Haemost (1999) 0.82
Psoriatic disease: concepts and implications. J Eur Acad Dermatol Venereol (2010) 0.82
Prevalence of diffuse idiopathic skeletal hyperostosis in a female Italian population. Clin Exp Rheumatol (2005) 0.82
Infliximab in the treatment of extra-intestinal manifestations of Crohn's disease. Scand J Rheumatol (2005) 0.81
Allergy and mucosal eosinophil infiltrate in ulcerative colitis. Scand J Gastroenterol (2000) 0.81
Primary antiphospholipid syndrome: a low-grade auto-inflammatory disease? Rheumatology (Oxford) (2008) 0.81
Hb Lepore and (haemo-) blastomata. Folia Haematol Int Mag Klin Morphol Blutforsch (1976) 0.80
Assessment of subclinical atherosclerosis in ankylosing spondylitis: correlations with disease activity indices. Reumatismo (2013) 0.80
Takayasu arteritis in a 66-year-old caucasian woman. Minerva Cardioangiol (2002) 0.80
Thrombophilic genotypes in subjects with idiopathic antiphospholipid antibodies--prevalence and significance. Thromb Haemost (1998) 0.80
Proteases and antiproteases in cartilage homeostasis. A brief review. Clin Orthop Relat Res (1994) 0.80
Psoriatic arthritis: treatment strategies using anti-inflammatory drugs and classical DMARDs. Reumatismo (2012) 0.80
The acromegalic arthropathy. J Endocrinol Invest (2005) 0.80
Axonal degeneration in systemic sclerosis can be reverted by factors improving tissue oxygenation. Rheumatology (Oxford) (2007) 0.79
In vitro inhibition by defibrotide of monocyte superoxide anion generation: a possible mechanism for the antithrombotic effect of a polydeoxyribonucleotide-derived drug. Haemostasis (1991) 0.79
Thalidomide in the treatment of the cutaneous manifestations of lupus erythematosus: experience in sixteen consecutive patients. Br J Rheumatol (1997) 0.79
Association of MICA alleles with psoriatic arthritis and its clinical forms. A multicenter Italian study. Clin Exp Rheumatol (2008) 0.79
Antioxidant susceptibility of pathogenic pathways in subjects with antiphospholipid antibodies: a pilot study. Lupus (2000) 0.79
Subcorneal pustular dermatosis (Sneddon-Wilkinson syndrome): another cutaneous manifestation of SAPHO syndrome? Br J Rheumatol (1997) 0.79
Coagulation activation and fibrinolytic imbalance in subjects with idiopathic antiphospholipid antibodies--a crucial role for acquired free protein S deficiency. Thromb Haemost (1996) 0.79
Juvenile rheumatoid arthritis, Crohn's disease and Turner's syndrome: a novel association. Clin Exp Rheumatol (1997) 0.79
Ulcerative colitis, seronegative spondyloarthropathies and allergic diseases: the search for a link. Scand J Gastroenterol (2002) 0.79
Inherited thrombophilic risk factors in a large cohort of individuals referred to Italian thrombophilia centers: distinct roles in different clinical settings. Haematologica (2001) 0.78
Fine structure of the accessory glands of the human male genital tract. Prog Clin Biol Res (1989) 0.78
Predictors of cancer mortality in elderly subjects. Eur J Epidemiol (1999) 0.78
[Migrant thrombophlebitis and blood hypercoagulability caused by probable activation of the Hageman factor-PTA system. (Clinical case)]. Cardiol Prat (1968) 0.78
Serum interleukin-6 in acute pancreatitis due to common bile duct stones. A reliable marker of necrosis. Recenti Prog Med (1997) 0.78
Comparison of the Recent-Onset Arthritis Disability questionnaire with the Health Assessment Questionnaire disability index in patients with rheumatoid arthritis. Clin Exp Rheumatol (2011) 0.78
Recommendations of the Italian Society for Rheumatology for the use of biologic (TNF-alpha blocking) agents in the treatment of psoriatic arthritis. Clin Exp Rheumatol (2006) 0.78
Predictive factors for partial remission according to the Ankylosing Spondylitis Assessment Study working group in patients with ankylosing spondylitis treated with anti-TNFα drugs. Reumatismo (2014) 0.78
Bilateral renal artery occlusion in a patient with primary antiphospholipid antibody syndrome: thrombosis, vasculitis or both? J Rheumatol (1992) 0.77
A "new" congenital haemorrhagic condition due to the presence of an abnormal factor X (factor X Friuli): study of a large kindred. Br J Haematol (1970) 0.77
Development of systemic lupus erythematosus after chemotherapy and radiotherapy for malignant thymoma. Br J Rheumatol (1995) 0.77
Diffuse idiopathic skeletal hyperostosis (DISH): a retrospective analysis. Clin Rheumatol (1996) 0.77